Although these mortality outcomes did not reach statistical significance, the event rates for all-cause and cardiac death were numerically lower in the acipimox group.
← all excerpts
Combination therapy of statin and acipimox versus statin monotherapy in acute myocardial infarction with hypertriglyceridemia: a multicenter propensity score-matched analysis.
1
—
—